{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:26:05Z","timestamp":1778037965750,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PAK 997\/1"],"award-info":[{"award-number":["PAK 997\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>For radiotherapy of head and neck cancer (HNC) magnetic resonance imaging (MRI) plays a pivotal role due to its high soft tissue contrast. Moreover, it offers the potential to acquire functional information through diffusion weighted imaging (DWI) with the potential to personalize treatment. The aim of this study was to acquire repetitive DWI during the course of online adaptive radiotherapy on an 1.5\u00a0T MR-linear accelerator (MR-Linac) for HNC patients and to investigate temporal changes of apparent diffusion coefficient (ADC) values of the tumor and subvolume levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>27 patients treated with curative RT on the 1.5\u00a0T MR-Linac with at least weekly DWI in treatment position were included into this prospective analysis and divided in four risk groups (HPV-status and localisation). Tumor and lymph node volumes (GTV-P\/GTV-N) were delineated on b\u2009=\u2009500\u00a0s\/mm<jats:sup>2<\/jats:sup> images while ADC maps were calculated using b\u2009=\u2009150\/200 and 500\u00a0s\/mm<jats:sup>2<\/jats:sup> images. Absolute and relative temporal changes of mean ADC values, tumor volumes and a high-risk subvolume (HRS) defined by low ADC tumor voxels (600\u2009&lt;\u2009ADC\u2009&lt;\u2009900\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>\u00a0mm<jats:sup>2<\/jats:sup>\/s) were analyzed. Relative changes of mean ADC values, tumor volumes and HRS were statistically tested using Wilcoxon-signed-rank test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Median pretreatment ADC value for all patients resulted in 1167\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>\u00a0mm<jats:sup>2<\/jats:sup>\/s for GTV-P and 1002\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>\u00a0mm<jats:sup>2<\/jats:sup>\/s for GTV-N while absolute pretreatment tumor volume yielded 9.1\u00a0cm<jats:sup>3<\/jats:sup> for GTV-P and 6.0\u00a0cm<jats:sup>3<\/jats:sup> for GTV-N, respectively. Pretreatment HRS volumes were 1.5\u00a0cm<jats:sup>3<\/jats:sup> for GTV-P and 1.3\u00a0cm<jats:sup>3<\/jats:sup> for GTV-P and GTV-N. Median ADC values increase during 35 fractions of RT was 49% for GTV-P and 24% for GTV-N during RT. Median tumor volume decrease was 68% and 52% for GTV-P and GTV-N with a median HRS decrease of 93% and 87%. Significant differences from 0 for mean ADC were observed starting from week 1, for tumor volumes from week 2 for GTV-P and week 1 for GTV-N and for HRS in week 1 for GTV-P and week 2 for GTV-N.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Longitudinal DWI acquisition in HNC is feasible on a MR-Linac during the course of online adaptive MR-guided radiotherapy. Changes in ADC and volumes can be assessed, but future work needs to explore the potential for biologically guided treatment individualization.<\/jats:p>\n            <jats:p>\n              <jats:italic>Trial registration:<\/jats:italic> NCT04172753, actual study start: 09.05.2018.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13014-025-02589-9","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T13:19:56Z","timestamp":1738156796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal assessment of diffusion-weighted imaging during magnetic resonance-guided radiotherapy in head and neck cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Simon","family":"Boeke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Habrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"Schick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Thorwarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2589_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","journal-title":"N Engl J Med"},{"key":"2589_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","volume":"126","author":"P Lassen","year":"2018","unstructured":"Lassen P, Lacas B, Pignon JP, Trotti A, Zackrisson B, Zhang Q, et al. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: the MARCH-HPV project. Radiother Oncol. 2018;126:107\u201315.","journal-title":"Radiother Oncol"},{"key":"2589_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","volume":"121","author":"A Linge","year":"2016","unstructured":"Linge A, Lohaus F, L\u00f6ck S, Nowak A, Gudziol V, Valentini C, et al. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2016;121:364\u201373.","journal-title":"Radiother Oncol"},{"key":"2589_CR4","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/hed.24892","volume":"39","author":"D Berwouts","year":"2017","unstructured":"Berwouts D, Madani I, Duprez F, Olteanu AL, Vercauteren T, Boterberg T, et al. Long-term outcome of (18) F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study. Head Neck. 2017;39:2264\u201375.","journal-title":"Head Neck"},{"key":"2589_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1200\/JCO.23.01308","volume":"42","author":"NY Lee","year":"2024","unstructured":"Lee NY, Sherman EJ, Sch\u00f6der H, Wray R, Boyle JO, Singh B, et al. Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma. J Clin Oncol. 2024;42:940\u201350.","journal-title":"J Clin Oncol"},{"key":"2589_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.radonc.2020.10.039","volume":"155","author":"A Michaelidou","year":"2021","unstructured":"Michaelidou A, Adjogatse D, Suh Y, Pike L, Thomas C, Woodley O, et al. 18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: a phase I study (FiGaRO). Radiother Oncol. 2021;155:261\u20138.","journal-title":"Radiother Oncol"},{"key":"2589_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.radonc.2022.03.021","volume":"171","author":"S Welz","year":"2022","unstructured":"Welz S, Paulsen F, Pfannenberg C, Reimold M, Reischl G, Nikolaou K, et al. Dose escalation to hypoxic subvolumes in head and neck cancer: a randomized phase II study using dynamic [(18)F]FMISO PET\/CT. Radiother Oncol. 2022;171:30\u20136.","journal-title":"Radiother Oncol"},{"key":"2589_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.radonc.2020.05.022","volume":"149","author":"S Zschaeck","year":"2020","unstructured":"Zschaeck S, L\u00f6ck S, Hofheinz F, Zips D, Saks\u00f8 Mortensen L, Z\u00f6phel K, et al. Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy. Radiother Oncol. 2020;149:189\u201396.","journal-title":"Radiother Oncol"},{"key":"2589_CR9","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.3390\/curroncol29110655","volume":"29","author":"D Lavigne","year":"2022","unstructured":"Lavigne D, Ng SP, O\u2019Sullivan B, Nguyen-Tan PF, Filion E, L\u00e9tourneau-Guillon L, et al. Magnetic resonance-guided radiation therapy for head and neck cancers. Curr Oncol. 2022;29:8302\u201315.","journal-title":"Curr Oncol"},{"key":"2589_CR10","first-page":"6","volume":"32","author":"KA Wahid","year":"2022","unstructured":"Wahid KA, Ahmed S, He R, van Dijk LV, Teuwen J, McDonald BA, et al. Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: results from a prospective imaging registry. Clin Transl Radiat Oncol. 2022;32:6\u201314.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR11","first-page":"121","volume":"36","author":"R Zukauskaite","year":"2022","unstructured":"Zukauskaite R, Rumley CN, Hansen CR, Jameson MG, Trada Y, Johansen J, et al. Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients. Clin Transl Radiat Oncol. 2022;36:121\u20136.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR12","doi-asserted-by":"publisher","first-page":"100608","DOI":"10.1016\/j.phro.2024.100608","volume":"31","author":"F Guerreiro","year":"2024","unstructured":"Guerreiro F, van Houdt PJ, Navest RJM, Hoekstra N, de Jong M, Heijnen BJ, et al. Validation of quantitative magnetic resonance imaging techniques in head and neck healthy structures involved in the salivary and swallowing function: accuracy and repeatability. Phys Imaging Radiat Oncol. 2024;31:100608.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"2589_CR13","doi-asserted-by":"publisher","first-page":"110046","DOI":"10.1016\/j.radonc.2023.110046","volume":"191","author":"J Habrich","year":"2024","unstructured":"Habrich J, Boeke S, Fritz V, Koerner E, Nikolaou K, Schick F, et al. Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner. Radiother Oncol. 2024;191:110046.","journal-title":"Radiother Oncol."},{"key":"2589_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.radonc.2022.07.020","volume":"174","author":"J Habrich","year":"2022","unstructured":"Habrich J, Boeke S, Nachbar M, Nikolaou K, Schick F, Gani C, et al. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac. Radiother Oncol. 2022;174:141\u20138.","journal-title":"Radiother Oncol."},{"key":"2589_CR15","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.phro.2024.100574","volume":"30","author":"ND Sijtsema","year":"2024","unstructured":"Sijtsema ND, Lauwers I, Verduijn GM, Hoogeman MS, Poot DHJ, Hernandez-Tamames JA, et al. Relating pre-treatment non-Gaussian intravoxel incoherent motion diffusion-weighted imaging to human papillomavirus status and response in oropharyngeal carcinoma. Phys Imaging Radiat Oncol. 2024;30:100574.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"2589_CR16","first-page":"100857","volume":"49","author":"HJG Smits","year":"2024","unstructured":"Smits HJG, Vink SJ, de Ridder M, Philippens MEP, Dankbaar JW. Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors. Clin Transl Radiat Oncol. 2024;49:100857.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR17","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1007\/s00330-023-09843-2","volume":"33","author":"Y Trada","year":"2023","unstructured":"Trada Y, Keall P, Jameson M, Moses D, Lin P, Chlap P, et al. Changes in serial multiparametric MRI and FDG-PET\/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer. Eur Radiol. 2023;33:8788\u201399.","journal-title":"Eur Radiol"},{"key":"2589_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.radonc.2014.01.004","volume":"110","author":"M Lambrecht","year":"2014","unstructured":"Lambrecht M, Van Calster B, Vandecaveye V, De Keyzer F, Roebben I, Hermans R, et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol. 2014;110:429\u201334.","journal-title":"Radiother Oncol"},{"key":"2589_CR19","doi-asserted-by":"publisher","first-page":"20210333","DOI":"10.1259\/bjr.20210333","volume":"95","author":"S Connor","year":"2022","unstructured":"Connor S, Anjari M, Burd C, Guha A, Lei M, Guerrero-Urbano T, et al. The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient. Br J Radiol. 2022;95:20210333.","journal-title":"Br J Radiol"},{"key":"2589_CR20","doi-asserted-by":"publisher","first-page":"100603","DOI":"10.1016\/j.phro.2024.100603","volume":"31","author":"E Aliotta","year":"2024","unstructured":"Aliotta E, Paudyal R, Diplas B, Han J, Hu YC, Hun OhJ, et al. Multi-modality imaging parameters that predict rapid tumor regression in head and neck radiotherapy. Phys Imaging Radiat Oncol. 2024;31:100603.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"2589_CR21","doi-asserted-by":"publisher","first-page":"109641","DOI":"10.1016\/j.radonc.2023.109641","volume":"183","author":"ASR Mohamed","year":"2023","unstructured":"Mohamed ASR, Abusaif A, He R, Wahid KA, Salama V, Youssef S, et al. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: results from an observational biomarker pre-qualification study. Radiother Oncol. 2023;183:109641.","journal-title":"Radiother Oncol"},{"key":"2589_CR22","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.3390\/curroncol29090495","volume":"29","author":"SP Ng","year":"2022","unstructured":"Ng SP, Cardenas CE, Bahig H, Elgohari B, Wang J, Johnson JM, et al. Changes in apparent diffusion coefficient (ADC) in serial weekly MRI during radiotherapy in patients with head and neck cancer: results from the PREDICT-HN study. Curr Oncol. 2022;29:6303\u201313.","journal-title":"Curr Oncol"},{"key":"2589_CR23","doi-asserted-by":"publisher","first-page":"616156","DOI":"10.3389\/fonc.2021.616156","volume":"11","author":"S Boeke","year":"2021","unstructured":"Boeke S, M\u00f6nnich D, van Timmeren JE, Balermpas P. MR-guided radiotherapy for head and neck cancer: current developments, perspectives, and challenges. Front Oncol. 2021;11:616156.","journal-title":"Front Oncol"},{"key":"2589_CR24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ijrobp.2020.12.015","volume":"109","author":"BA McDonald","year":"2021","unstructured":"McDonald BA, Vedam S, Yang J, Wang J, Castillo P, Lee B, et al. Initial feasibility and clinical implementation of daily MR-guided adaptive head and neck cancer radiation therapy on a 1.5T MR-Linac system: prospective R-IDEAL 2a\/2b systematic clinical evaluation of technical innovation. Int J Radiat Oncol Biol Phys. 2021;109:1606\u201318.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2589_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.phro.2020.09.007","volume":"16","author":"D Thorwarth","year":"2020","unstructured":"Thorwarth D, Ege M, Nachbar M, M\u00f6nnich D, Gani C, Zips D, et al. Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: perspective on technical and clinical validation. Phys Imaging Radiat Oncol. 2020;16:69\u201373.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"2589_CR26","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1007\/s00259-023-06254-9","volume":"50","author":"S Boeke","year":"2023","unstructured":"Boeke S, Winter RM, Leibfarth S, Krueger MA, Bowden G, Cotton J, et al. Machine learning identifies multi-parametric functional PET\/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models. Eur J Nucl Med Mol Imaging. 2023;50:3084\u201396.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2589_CR27","doi-asserted-by":"publisher","first-page":"110702","DOI":"10.1016\/j.radonc.2024.110702","volume":"204","author":"RM Winter","year":"2025","unstructured":"Winter RM, Boeke S, Leibfarth S, Habrich J, Clasen K, Nikolaou K, et al. Clinical validation of a prognostic preclinical magnetic resonance imaging biomarker for radiotherapy outcome in head-and-neck cancer. Radiother Oncol. 2025;204:110702.","journal-title":"Radiother Oncol"},{"key":"2589_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.radonc.2020.09.046","volume":"153","author":"ES Kooreman","year":"2020","unstructured":"Kooreman ES, van Houdt PJ, Keesman R, Pos FJ, van Pelt VWJ, Nowee ME, et al. ADC measurements on the Unity MR-linac\u2014a recommendation on behalf of the Elekta Unity MR-linac consortium. Radiother Oncol. 2020;153:106\u201313.","journal-title":"Radiother Oncol"},{"key":"2589_CR29","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1063\/1.1696526","volume":"43","author":"EO Stejskal","year":"1965","unstructured":"Stejskal EO. Use of spin echoes in a pulsed magnetic-field gradient to study anisotropic, restricted diffusion and flow. J Chem Phys. 1965;43:3597\u2013603.","journal-title":"J Chem Phys"},{"key":"2589_CR30","doi-asserted-by":"publisher","first-page":"109717","DOI":"10.1016\/j.radonc.2023.109717","volume":"185","author":"BA McDonald","year":"2023","unstructured":"McDonald BA, Salzillo T, Mulder S, Ahmed S, Dresner A, Preston K, et al. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers. Radiother Oncol. 2023;185:109717.","journal-title":"Radiother Oncol"},{"key":"2589_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mri.2024.03.020","volume":"111","author":"OL Wong","year":"2024","unstructured":"Wong OL, Yuan J, Poon DMC, Chiu ST, Yang B, Chiu G, et al. Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator. Magn Reson Imaging. 2024;111:47\u201356.","journal-title":"Magn Reson Imaging."},{"key":"2589_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.radonc.2016.10.012","volume":"122","author":"O Hamming-Vrieze","year":"2017","unstructured":"Hamming-Vrieze O, van Kranen SR, Heemsbergen WD, Lange CAH, van den Brekel MWM, Verheij M, et al. Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: implications for adaptive radiotherapy. Radiother Oncol. 2017;122:224\u20138.","journal-title":"Radiother Oncol"},{"key":"2589_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-015-1154-8","volume":"15","author":"M Subesinghe","year":"2015","unstructured":"Subesinghe M, Scarsbrook AF, Sourbron S, Wilson DJ, McDermott G, Speight R, et al. Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study. BMC Cancer. 2015;15:137.","journal-title":"BMC Cancer"},{"key":"2589_CR34","first-page":"100666","volume":"42","author":"DM El-Habashy","year":"2023","unstructured":"El-Habashy DM, Wahid KA, He R, McDonald B, Rigert J, Mulder SJ, et al. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-Linear accelerator hybrid system: a prospective R-IDEAL Stage 2a imaging biomarker characterization\/pre-qualification study. Clin Transl Radiat Oncol. 2023;42:100666.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13014-018-0967-4","volume":"13","author":"H Bahig","year":"2018","unstructured":"Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, et al. Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy (MR-ADAPTOR): an R-IDEAL stage 2a\u20132b\/Bayesian phase II trial. Clin Transl Radiat Oncol. 2018;13:19\u201323.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR36","first-page":"11","volume":"11","author":"ASR Mohamed","year":"2018","unstructured":"Mohamed ASR, Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, et al. Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT. Clin Transl Radiat Oncol. 2018;11:11\u20138.","journal-title":"Clin Transl Radiat Oncol"},{"key":"2589_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/mrm.1910340111","volume":"34","author":"P Jezzard","year":"1995","unstructured":"Jezzard P, Balaban RS. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med. 1995;34:65\u201373.","journal-title":"Magn Reson Med"},{"key":"2589_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ejrad.2007.10.008","volume":"69","author":"J Sakamoto","year":"2009","unstructured":"Sakamoto J, Yoshino N, Okochi K, Imaizumi A, Tetsumura A, Kurohara K, et al. Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE. Eur J Radiol. 2009;69:260\u20138.","journal-title":"Eur J Radiol"},{"key":"2589_CR39","doi-asserted-by":"publisher","first-page":"e0152472","DOI":"10.1371\/journal.pone.0152472","volume":"11","author":"JM Treiber","year":"2016","unstructured":"Treiber JM, White NS, Steed TC, Bartsch H, Holland D, Farid N, et al. Characterization and correction of geometric distortions in 814 diffusion weighted images. PLoS ONE. 2016;11:e0152472.","journal-title":"PLoS ONE"},{"key":"2589_CR40","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1002\/mp.12363","volume":"44","author":"T Schakel","year":"2017","unstructured":"Schakel T, Hoogduin JM, Terhaard CHJ, Philippens MEP. Technical note: diffusion-weighted MRI with minimal distortion in head-and-neck radiotherapy using a turbo spin echo acquisition method. Med Phys. 2017;44:4188\u201393.","journal-title":"Med Phys"},{"key":"2589_CR41","doi-asserted-by":"publisher","first-page":"109803","DOI":"10.1016\/j.radonc.2023.109803","volume":"186","author":"ALH Bisgaard","year":"2023","unstructured":"Bisgaard ALH, Keesman R, van Lier A, Coolens C, van Houdt PJ, Tree A, et al. Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group. Radiother Oncol. 2023;186:109803.","journal-title":"Radiother Oncol"},{"key":"2589_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13014-022-02178-0","volume":"18","author":"T Ermongkonchai","year":"2023","unstructured":"Ermongkonchai T, Khor R, Wada M, Lau E, Xing DT, Ng SP. A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia. Radiat Oncol. 2023;18:20.","journal-title":"Radiat Oncol"},{"key":"2589_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijrobp.2010.05.051","volume":"81","author":"M Hatakenaka","year":"2011","unstructured":"Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Ohnishi K, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys. 2011;81:339\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2589_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ejrad.2014.02.013","volume":"83","author":"T Hauser","year":"2014","unstructured":"Hauser T, Essig M, Jensen A, Laun FB, M\u00fcnter M, Maier-Hein KH, et al. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur J Radiol. 2014;83:783\u20137.","journal-title":"Eur J Radiol"},{"key":"2589_CR45","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s00330-019-06426-y","volume":"30","author":"B Peltenburg","year":"2020","unstructured":"Peltenburg B, Driessen JP, Vasmel JE, Pameijer FA, Janssen LM, Terhaard CHJ, et al. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known. Eur Radiol. 2020;30:1228\u201331.","journal-title":"Eur Radiol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02589-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T13:20:00Z","timestamp":1738156800000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2589"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02589-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the local ethical committee (no. 659\/2017BO1, NCT04172753) and all patients gave their written informant consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Approval for publication of patient images was included in all patients\u2019 written informant consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Department of Radiation Oncology T\u00fcbingen receives financial and technical support by Elekta, Philips, Dr. Sennewald Medizintechnik, Kaiku Health, TheraPanacea, PTW Freiburg, ITV and Brainlab in the context of research cooperations. The Department of Diagnostic and Interventional Radiology, University of T\u00fcbingen reports institutional collaborations, consultation and grants supported Siemens Healthineers, Erlangen, Germany and Bayer Healthcare, Leverkusen, Germany outside this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}